Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2

Leukemia

Volumn 25, Issue 10, 2011, Pages 1632-1635

  Chen, S ^a,b   Nagel, S ^a   Schneider, B ^a   Kaufmann, M ^a   Meyer, C ^a   Zaborski, M ^a   Kees, U R ^c   Drexler, H G ^a   MacLeod, R A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIM DOMAIN ONLY 2 PROTEIN; LIM KINASE; MEMBRANE PROTEIN; MUSCLEBLIND LIKE PROTEIN 1; STROMAL ANTIGEN 2; UNCLASSIFIED DRUG;

CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE REARRANGEMENT; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; LETTER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, NUCLEAR; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, X; HUMANS; LIM DOMAIN PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TRANSLOCATION, GENETIC;

EID: 80054044030     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.119     Document Type: Letter

References (10)

1. Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006; 108: 3520-3529.
2. Dik WA, Nadel B, Przybylski GK, Asnafi V, Grabarczyk P, Navarro J et al. Different chromosome breakpoints impact levels of LMO2 expression in T-ALL. Blood 2007; 110: 388-392. (Pubitemid 47026860)
3. Kees UR, Ford J, Price PJ, Meyer BF, Herrmann RP. PER-117: a new human ALL cell line with an immature thymic phenotype. Leuk Res 1987; 11: 489-498. (Pubitemid 17065232)
4. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443-1448. (Pubitemid 36988055)
5. Barber T, McManus K, Yuen K, Reis M, Parmigiani G, Shen D et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci USA 2008; 105: 3443-3448. (Pubitemid 351723572)
6. King D, Taylor J, Zhang Y, Cheng Y, Lawson H, Martin J et al. Finding cis-regulatory elements using comparative genomics. Genome Res 2007; 17: 775-786.
7. Van Vlierberghe P, Beverloo HB, Buijs-Gladdines J, van Wering ER, Horstmann M, Pieters R et al. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2008; 22: 1434-1437. (Pubitemid 352006089)
8. Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M et al. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 30-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res 2007; 67: 1461-1471. (Pubitemid 46389240)
9. McCormack MP, Forster A, Drynan L, Pannell R, Rabbitts TH. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 2003; 23: 9003-9013. (Pubitemid 37499791)
10. McCormack MP, Young LF, Vasudevan S, de Graaf CA, Codrington R, Rabbitts TH et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010; 327: 879-883.